Cytosolic sensing of nucleic acids initiates tightly regulated programs to limit infection. Oocyte fertilization represents a scenario wherein inappropriate responses to exogenous yet non-pathogen-derived nucleic acids would have negative consequences. We hypothesized that germ cells express negative regulators of nucleic acid sensing (NAS) in steady state and applied an integrated data-mining and functional genomics approach to identify a rheostat of DNA and RNA sensing-the inflammasome component NLRP14. We demonstrated that NLRP14 interacted physically with the nucleic acid sensing pathway and targeted TBK1 (TANK binding kinase 1) for ubiquitination and degradation. We further mapped domains in NLRP14 and TBK1 that mediated the inhibitory function. Finally, we identified a human nonsense germline variant associated with male sterility that results in loss of NLRP14 function and hyper-responsiveness to nucleic acids. The discovery points to a mechanism of nucleic acid sensing regulation that may be of particular importance in fertilization.
In Brief
Cytosolic sensing of nucleic acids limits infection, but fertilization represents a scenario when responses to exogenous, non-pathogen-derived nucleic acids would be detrimental. Abe et al. identify NLRP14 as an evolutionarily conserved immunological rheostat that safeguards against such responses, which may have been a prerequisite for the evolution of sexual reproduction.
INTRODUCTION
Virtually all organisms have some form of system, whether cellular or molecular, that functions to protect their metabolic requirements for life-or in simpler terms, for replicating their genomes. From bacteria and protozoans to insects and humans, organisms have a means of distinguishing self from non-self and mounting appropriate responses to foreign agents. The innate immune system, which is conserved across virtually all multi-cellular organisms on the planet (from sponges to insects, plants, and vertebrates), includes a diverse set of receptors capable of detecting molecular patterns like sugars, lipids, polymers, and nucleic acids that are principal in prompting these responses (Kumar et al., 2011a) .
In vertebrates, cytosolic detection of nucleic acids is critical for initiating innate (characterized by production of type I interferons; IFN-a/b) and adaptive immune responses to invading pathogens (Wu and Chen, 2014) . However, these inflammatory programs must be tightly regulated to prevent aberrant responses to self nucleic acids. Indeed, RIG-I (retinoic acid-inducible gene 1), the cytosolic receptor for RNA, distinguishes self from non-self RNA through interaction with a 5 0 -triphosphate that is unique to viral RNA (Wu and Chen, 2014) . As DNA is not physiologically found in the cytoplasm, cytosolic DNA sensing, mediated by cGAS (cyclic GMP-AMP synthase) in collaboration with STING (stimulator of interferon genes), does not distinguish between self and non-self DNA (Nagata et al., 2010) . However, during fertilization, sperm cell-derived DNA can be found in oocyte cytoplasm and could a trigger nucleic acid-sensing response. We therefore reasoned that germ cells must possess a robust mechanism to negatively regulate cytosolic nucleic acid sensing.
To identify negative regulators of cytosolic nuclei acid sensing, we mined RNA sequencing (RNA-seq) data from various human tissues for transcripts found specifically in germ cells that were downregulated after fertilization. We subsequently performed a functional genomics screen on these candidate genes and identified NLRP14 (NACHT, LRR and PYD domains-containing 14; a component of the inflammasome family of proteins) as a rheostat for nucleic acid sensing. We demonstrated that ectopic expression of NLRP14 resulted in loss of signaling through the cytosolic nucleic acid-sensing pathways. Conversely, CRISPR-mediated (clustered regulatory interspaced short palindromic repeats) targeting of this gene resulted in enhanced DNA and RNA sensing and augmented production of pro-inflammatory cytokines. We showed that NLRP14 interacted physically with components of the nucleic acid sensing pathway, including STING, RIG-I, MAVS (mitochondrial antiviral signaling protein), and TBK1. In addition, we determined that NLRP14 targeted TBK1 for ubiquitination and degradation and delineated domains in NLRP14 and TBK1 that mediate the interactions as well as the inhibitory function. Finally, we identified a human nonsense germline variant associated with male sterility that results in loss of NLRP14 function and exaggerated responses to nucleic acids.
RESULTS

NLRP14 Is a Candidate Modulator of Cytosolic Nucleic Acid Sensing
We reasoned that expression of a potent negative regulator of NAS may be of particular importance for germ cells during fertilization. Indeed, key members of the NAS pathway are expressed in oocytes and probably constitute the same functions they have in detecting nucleic acids in non-germ cells (Table S1 ). We mined the Genotype-Tissue Expression (GTEx) (http://commonfund. nih.gov/GTEx/index) database to identify genes preferentially expressed in testes and ovary (the tissues most relevant to fertilization). Our analysis yielded 1,180 genes with expression in testes and/or ovaries and low or absent expression in all other tissues (Figure 1 ; see Experimental Procedures for a full description of the analysis). We further limited the candidate gene list by focusing on genes whose expression is downregulated after fertilization (Yan et al., 2013; see Experimental Procedures) , as NAS inhibition would be required during fertilization but dispensable and perhaps even deleterious thereafter. Thus, we identified 20 candidate genes that were preferentially expressed in germ cells and downregulated after fertilization.
We next performed an overexpression screen of these candidate genes to determine whether they regulated cytosolic DNAsensing pathways in 293T cells, which have been extensively explored as a model system for nucleic acid sensing. Specifically, 293T cells do not normally express the cytosolic DNA sensors cGAS and its signal adaptor STING. This allowed us to generate cells where this pathway was reconstituted through stable expression of HA-tagged STING (293T-STING-HA) for use in the gain-of-function screen. Each of the 20 candidates genes was subcloned into a lentiviral-based expression vector (pLenti6.2-V5) and co-transfected with cGAS and an IFN-stimulated response element (ISRE) promoter driving expression of luciferase (ISRE-luc) into 293T-STING-HA cells (Figure 1 ; of the 20 candidates, 17 were successfully cloned and expressed by the pLenti6.2-V5 vector). Our targeted screen indicated that five of the candidates suppressed cGAS-mediated ISRE promoter activation by 40% or more (TRIM42, TGIF2LX, C4orf42, ZPLD1, and NLRP14). Of these, we focused on NLRP14, a member of the inflammasome family of proteins (Schattgen and Fitzgerald, 2011) , which achieved the highest suppression of cGASmediated signaling (Figure 1, right) . Indeed, we also confirmed that NLRP14 expression was rapidly downregulated after fertilization ( Figure S1A ). In short, our combined unbiased computational and experimental approach resulted in the identification of NLRP14 as a putative inhibitor of NAS during fertilization.
NLRP14 Negatively Regulates Pattern Recognition Receptor-Mediated Signaling
The cytosolic sensing of DNA is regulated by cGAS in collaboration with the endoplasmic reticulum (ER)-associated multiple transmembrane protein STING (Barber, 2015; Cai et al., 2014) . Downstream signaling activates IRF3-and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB)-dependent transcription that induces the production and secretion of type I interferons (such as IFN-b) and other pro-inflammatory cytokines ( Figure 2A) . A key member of this pathway is TBK1, which phosphorylates IRF3 and, to a lesser extent, IRF7. To examine the effect of NLRP14 on cytosolic DNA-sensing pathway in more detail, HA-tagged-STING, or FLAG-tagged-TRIF, TBK1, IRF3, and IRF7 were co-transfected with N-terminal Myc-tagged-NLRP14 (Myc-NLRP14) together with ISRE or NF-kB reporter plasmids into 293T cells (Figures 2B and 2C) . We found that transduction of Myc-NLRP14 significantly reduced ISRE-and NF-kB-mediated promoter activation in the context of STING, TRIF, TBK1, and IRF3, but not IRF7 (Figures 2B and 2C) , suggesting that NLRP14 preferentially targets IRF3-dependent signaling. The effect on TBK1 (the kinase that is critical for signaling downstream of cytosolic sensing of both DNA and RNA) suggested a more general role for NLRP14 in dampening PRR signaling. Consistent with this, we found that NLRP14 reduced RIG-I-and MAVS-induced activation of ISRE-and NF-kB-mediated promoters ( Figure 2D ). Indeed, TBK1-mediated induction of endogenous C-X-C motif chemokine ligand 10 (IP10) and IFN-b mRNA expression was suppressed by NLRP14 in a dose-dependent manner ( Figure 2E ).
While not normally expressed physiologically in somatic tissues, we found that cancer and immortalized cell lines including 293T cells and primary human bronchial epithelial cells (HBECs) express modest levels of NLRP14 ( Figure S1B ). Therefore, to further confirm NLRP14's involvement in modulating cGAS-STING-triggered signaling, we targeted NLRP14 via CRISPR-Cas9-mediated gene silencing in 293T cells stably expressing HA-tagged STING (293T-STING-HA-NLRP14-CRISPR; Figure S2B ). Figures  S1C and S1D ).
To further explore the role of NLRP14 as a general dampener of NAS, we again took advantage of CRISPR-Cas9-mediated genome editing to establish NLRP14-deficient 293T cells (which do not express STING). Sequencing of genomic DNA derived from 293T-NLRP14-CRISPR cells revealed a 23-nucleotide deletion within the targeted exon ( Figure S2 ).
We first monitored innate immune activation through the indirect measurement of type I interferons in supernatants from cells stimulated with ligands of the RNA nucleic-sensing pathway: B-DNA, poly(I:C) (polyinosinic:polycytidylic acid), and the RNA virus Newcastle disease virus (NDV). We found that cells lacking NLRP14 were more responsive to ligand stimulation and RNA virus infection as compared to WT controls ( Figures 3B and 3C ). Of note, transfection efficiency of rhodamine-labeled B-DNA in 293T-NLRP14-CRISPR cells was equivalent to that of parental cells ( Figure S2C) , and thus the hyper-responsive phenotype observed in 293T-NLRP14-CRISPR cells was not simply due to differences in ligand uptake. Stimulation with B-DNA or NDV infection resulted in significant enhancement of endogenous mRNA gene expression, including IP10, IFN-b, IRF7, and ISG15 (interferon stimulated gene 15) ( Figure 3D ). Furthermore, exogenous expression of STING, RIG-I, TBK1, and MAVS resulted in enhanced transcription of IP10 and IFN-b in 293T-NLRP14-CRISPR cells ( Figure 3D ). Collectively, these results demonstrate that while overexpression of NLRP14 results in dampening of NAS, deletion of endogenous NLRP14 expression results in augmented NAS-mediated signaling and anti-viral immunity. Thus, NLRP14 functionally serves as a potent negative regulator of cytosolic sensing of nucleic acids.
NLRP14 Associates Physically with Components of NAS
Activation of cGAS (through interaction with DNA) leads to the production of cGAMP, a second messenger molecule that in turn triggers STING-mediated activation of TBK1. To investigate how NLRP14 counteracts cGAS/STING-and RIG-I-mediated signal transduction, we explored whether NLRP14 interacts with components of the cytosolic NAS machinery (Figure 4) . We first interrogated whether NLRP14 associates with exogenously expressed cGAS and/or STING independently of downstream signaling and found that it interacted with STING but not cGAS in WT 293T cells ( Figure 4A ). Next, Myc-NLRP14 was expressed in the presence or absence of HA-cGAS in 293T-STING-HA cells followed by immunoprecipitation with anti-HA and immunoblotting with an anti-Myc antibody (Figure 4 ). While we observed slight precipitation of NLRP14 with STING, it was enhanced in the presence of cGAS ( Figures 4A and 4B ), suggesting that NLRP14 may participate in the DNA sensing pathway through interaction with activated STING. Although cGAS-mediated STING activation, such as phosphorylation and degradation, were intact, STING-TBK1 interaction as well as phosphorylation of IRF3 was reduced in the presence of NLRP14 (Figures 4B and 4C) . Together, these results suggested that NLRP14 does not inhibit STING-mediated signaling via the cGAS-STING axis. Rather, NLRP14 suppresses downstream activation of IRF3 by interfering with STING-TBK1 signaling complexes.
We next sought to determine whether NLRP14 interacts with molecules that participate in RIG-I-mediated signaling. To examine this possibility, Myc-NLRP14 was co-expressed with Flag-tagged versions of RIG-I, MAVS, TBK1, or IRF3 followed by immunoprecipitation with anti-Flag and immunoblotting with anti-Myc antibody ( Figures 4D-4F and Figure S3D ). We found that NLRP14 interacts not only with TBK1 but also with each of the other signaling molecules tested (RIG-I, MAVS, and IRF3), although its interaction with IRF3 was modest ( Figure 4D ). In addition, cells transduced with NLRP14 exhibited suppression of IRF3 phosphorylation both in the presence and absence of NDV infection (which triggers TBK1-mediated IRF3 activation; Figure S3 ). Similarly, NLRP14 expression suppressed Ser172 phosphorylation of TBK1 and Ser536 phosphorylation of NF-kB p65 ( Figure S3A , indicated panels). We observed significant increase in TBK1 and IRF3 phosphorylation in 293T-NLRP14-CRISPR cells in the context of TBK1 overexpression as well as in response to NDV infection . In contrast, similar to the results shown in Figure 2 , infection-induced phosphorylation of IRF7 was not inhibited by NLRP14, suggesting possible specificity in NLRP14 function ( Figure S3B ). Together with the observation that NLRP14 influences formation of STING-TBK1 complexes, these results indicated that NLRP14 neutralizes cytosolic sensing of nucleic acids at the level of TBK1 through direct interaction with complexes critical for IRF3 phosphorylation and immune activation.
N-Terminal Domains of NLRP14 Are Required for Suppression of TBK1-Mediated IFN-b Production
We sought to determine the functional protein elements in NLRP14 responsible for modulating TBK1-mediated signaling. We constructed N-terminal deletion mutants of NLRP14 lacking amino acids 1 to 100 (D1-100) and 1 to 345 (D1-345) as well as a C-terminal deletion mutant lacking amino acids 531 to 1,093 (D531-1,093) and monitored their capacity to affect NAS signaling ( Figure 5 ). Consistent with our previously described observations (Figure 3 ), neither full-length nor any of the NLRP14 variants tested suppressed IRF7-mediated ISRE promoter activation ( Figure S3E ). However, while D1-100 and D531-1,093 significantly inhibited TBK1-mediated IFN-b and NF-kB promoter activation, deletion of amino acids 1-345 (D1-345) resulted in abolishment of the inhibitory function ( Figure 5B ). This 5C ). On the other hand, the NACHT domain of NLRP14 (consisting of amino acid residues 176-345) was not sufficient to suppress TBK1-mediated promoter activation ( Figure S4 ), suggesting a redundant role for this domain in modulating NAS signaling. To further investigate how the N-terminal region of NLRP14-which includes both PYD and NACHT domains-contributes to inhibiting signaling downstream of STING-cGAS and RIG-I, we examined their requirement for NLRP14-TBK1 interaction. We found that loss of amino acids 1-345 (D1-345; containing both PYD and NACHT domains) resulted in complete abolishment of TBK1 co-immunoprecipitation, indicating that this region is required for NLRP14 interaction and suppression of TBK1 signaling ( Figures 5D and 5E ). Similarly, we sought to determine domains in TBK1 responsible for its interaction with NLRP14. To this end, Flag-tagged TBK1 variants (1-383 and 1-305, lacking the coiled-coil [CC] domain and the ubiquitin-like domain [ULD] as well as the CC domain, respectively) were co-transfected along with Myc-NLRP14 into 293T cells and monitored for interaction through immunoprecipitation (using anti-Flag antibody) followed by immunoblotting (with anti-Myc antibody; Figures  6B and 6D ). As shown in Figure 6D , aa 1-305 were sufficient for TBK1-NLRP14 binding, suggesting that the N-terminal kinase domain (KD) of TBK1 participates in this interaction. We also found that a kinase-dead mutant of TBK1 (S172A) did not abrogate interaction with NLRP14 ( Figure 6C ), implying that kinase activity was not required for its association with NLRP14 and suggesting that the suppression of TBK1-mediated signaling by NLRP14 was not likely to be associated with the modulation of TBK1 kinase activity.
NLRP14 Induces Ubiquitination and Degradation of TBK1
Given the physical interaction between NLRP14 and TBK1, we next sought to determine how NLRP14 abrogates TBK1-dependent signaling. Exogenous expression of NLRP14 resulted in a decrease in TBK1 protein in both the presence and absence of NDV infection ( Figures 5C and S3 ). We therefore hypothesized that the ubiquitination pathway may provide clues to the molecular mechanism through which NLRP14 targets TBK1 for degradation; Flag-TBK1, Myc-NLRP14, and HA-tagged ubiquitin (HA-Ub) were co-transduced in 293T cells followed by immunoprecipitation by anti-Flag and immunoblotting with anti-HA antibody. We found that NLRP14 expression led to poly-ubiquitination of TBK1 ( Figure 6E ) and resulted in a reduction in TBK1 levels. Importantly, NLRP14 loss-of-function mutants (D1-345;
which do not interfere with TBK1-mediated signaling; Figure 5 ), failed to induce poly-ubiquitination of TBK1 ( Figure 6F, lane 3) . Previous studies have indicated that TBK1 may be subject to lysine 48 (K48) and lysine 63 (K63) poly-ubiquitination (which control degradation and activation of TBK1, respectively; Zhao, 2013). We observed that K48R and K63R mutations in ubiquitin did not alter NLRP14-induced poly-ubiquitination of TBK1 ( Figure 6G ), suggesting that TBK1 may be targeted for degradation in a K48-ubiquitin-independent manner. Moreover, we observed that similar to full-length TBK1, DCC and DULD-CC variants (which did not alter interactions with NLRP14; Figure 6D ) still underwent NLRP14-dependent poly-ubiquitination (Figure 6H) . Together, these results indicated that the kinase domain of TBK1 was sufficient for its interaction with NLRP14 and subsequent targeting for degradation. Recently, Cui et al. (2012) proposed that NLRP4 (a member of the inflammasome family of proteins that shares 38% homology with NLRP14) negatively regulates RNA sensing by targeting TBK1 for ubiquitination and proteasomal degradation. We explored whether NLRP4 and NLRP14 have overlapping or redundant functions. Indeed, similarly to the observations previously reported, we generated NLRP4-CRISPR-293T cells and found that they exhibited enhanced responses to NDV infection and poly(I:C) transfection ( Figures S5A and S5B) , suggesting a possible similarity between NLRP4-and NLRP14-mediated immunosuppression. However, exogenous expression of NLRP14 in NLRP4-CRISPR-293T cells resulted in induction of TBK1 ubiquitination, suppression of TBK1 phosphorylation, as well as inhibition of TBK1-mediated ISRE and NF-kB promoter activation ( Figures S5C and S5D) , indicating an NLRP4-independent, NLRP14-dependent inhibition of this pathway. Furthermore, we found that NLRP14 suppressed a mutant version of TBK1 where lysine 670 (which is associated with DTX4-dependent ubiquitination and degradation of TBK1) was replaced with an arginine (K670R; Figures S6C-S6E) , suggesting a non-redundant role for NLRP14 in modulating TBK1-dependent signaling through an as of yet unknown E3 ligase in a K670-independent manner. So, while further studies are needed to clarify the molecular mechanism by which NLRP14 induces ubiquitination and degradation of TBK1, these data indicated that it may serve as a safeguard against inappropriate sensing of nucleic acids in germ cells.
A Negative Feedback Loop Regulates NLRP14 Action on NAS
The mitochondrially localized scaffold protein MAVS is a critical adaptor molecule for signal transduction downstream of RIG-Imediated sensing of RNA (Kawai and Akira, 2006) . As shown in Figure 4D , we found that NLRP14 interacts with MAVS (along with STING, RIG-I, TBK1, and IRF3). However, we also observed that expression of these signaling molecules resulted in reduction of NLRP14 protein levels. In particular, MAVS and STING expression led to marked decreases in NLRP14 protein ( Figures  4A and 4D ). Previous reports have demonstrated that the transmembrane region of MAVS (consisting of amino acids 514-535) is required for proper mitochondrial localization and signaling (Baril et al., 2009; Seth et al., 2005) . We found that expression of MAVS lacking the transmembrane domain (MAVSDTM) resulted in complete abrogation of the NLRP14 interaction and MAVS-induced loss of NLRP14 expression ( Figure 4E) . Similarly, STING, but not a loss-of-function mutant (I200N), interacted with NLRP14 and induced loss of expression ( Figure 4F ), suggesting that functional signaling was required. To determine the pathway responsible for controlling NLRP14 levels, cells were treated with the proteasome inhibitor MG132 or the autophagy inhibitor Bafilomycin A1. While MAVS-induced loss of NLRP14 levels was resistant to Bafilomycin A1 treatment, we found that MG132 treatment resulted in recovery of NLRP14 protein ( Figure S6F ). Together, these results suggested that proper MAVS localization and signaling were required for inducing a proteasome-dependent process that led to the degradation of NLRP14. Finally, to determine the element responsible for controlling the degradation of NLRP14, Myc-tagged variants of NLRP14 lacking PYD, NACHT, and LRR were transfected into 293T cells in presence or absence of MAVS or STING (Figures S6A and S6B) . Although deleting PYD (DPYD) and NACHT (DNACHT) domains in NLRP14 did not affect MAVS-or STING-induced depletion, deletion of the LRR domain (DLRR) resulted in resistance to degradation, suggesting that the LRR controls NLRP14 protein stability (Figures S6A and S6B) . Furthermore, we found that increased stability of DLRR-NLRP14 resulted in enhanced capacity to suppress TBK1-and STING-mediated IFN-b promoter activation in a dose-dependent manner ( Figures S6A and S6B ). As with other NLRP proteins (Martinon et al., 2002) , we suspect that NLRP14 exists in two conformations that differentially regulate protein function and that deletion of the LRR results in exposure of the functional PYD and NACHT domains that participate in inhibiting the cytosolic nucleic acid sensing pathways. The existence of such tight on/off regulation may ensure that persistent immunosuppression by NLRP14 does not occur ( Figure 7E ).
Naturally Occurring SNPs in NLRP14 Result in Reduced Inhibition of the Nucleic Acid Sensing Pathway
Previous reports have suggested a role for NLRP14 in embryo development (Yurttas et al., 2010) and one study identified SNPs within the several genes including NLRP14 in sterile men with spermatogenic failure (Westerveld et al., 2006) . These included missense mutations D86V, A375T, D522Q, M1019I, as well as K108X that introduces a stop codon at aa 108 (Westerveld et al., 2006) . With the exception of the K108X allele, these SNPs are extremely rare in the human population (%0.0001%; 1000 Genome Project). Though a functional relationship between these mutations and spermatogenic failure and/or sterility remains elusive, we hypothesized that they may regulate NLRP14 immunosuppressive function. We generated full-length NLRP14 expression constructs containing each of the reported mutations and functionally interrogated their capacity to inhibit TBK1-mediated signaling (Figures 7 and S7A ). We found that NLRP14 variants harboring missense mutations inhibited TBK1-mediated activation of IFN-b and NF-kB promoters, impaired TBK1 and IRF3 phosphorylation, and resulted in the loss of TBK1 expression similarly to wild-type NLRP14 (Figure S7A) . In contrast, we observed that the K108X mutation, which introduces a stop codon at aa 108, resulted in impaired inhibition of TBK1-mediated activation of both IFN-b and NF-kB promoter activation ( Figure 7B ). Furthermore, this corresponded to significant recovery of TBK1 levels, TBK1 and IRF3 phosphorylation, and IFN-b and IP10 mRNA expression ( Figures 7C and  S7B) . Moreover, co-immunoprecipitation analysis revealed that K108X-NLRP14 did not associate with TBK1 ( Figure 7D ) and induced markedly lower polyubiquitination of TBK1 ( Figure 6F ), further demonstrating a loss of normal NLRP14-mediated function. Since the possibility exists for transcriptional read-through in the K108X-NLRP14 construct (resulting in full-length protein), we sought to confirm our findings by constructing a Flag-tagged C-terminal deletion mutant possessing exclusively amino acid residues 1-108 of NLRP14 (referred to as 1-108-FL; Figures  S7C-S7F) . Indeed, 1-108-FL failed to inhibit TBK1-induced IFN-b and NF-kB promoter activation as well as endogenous IFN-b and IP10 mRNA expression. However, we observed that signaling was partially enhanced as compared to full-length NLRP14 ( Figures S7C-S7F) , consistent with our observation that both PYD and NACHT domains are required for NLRP14's inhibitory function. Together, these data suggested that loss of NLRP14 function could result in inappropriate induction of PRR-mediated immune responses that may lead to spermatogenic failure and infertility. Further studies, including small animal models, will be critical in further delineating the molecular mechanism and developmental role of NLRP14 and naturally occurring SNPs in modulating cytosolic sensing of nucleic acids.
DISCUSSION
Recent advances have revealed that some members of the inflammasome family of proteins may be involved not only in pathogen recognition but also in the regulation of tissue homeostasis (Kufer and Sansonetti, 2011; Rathinam and Fitzgerald, 2016) . Though several NLRPs (like NLRP2, 4, 5, 7, 9, and 14) were shown to be expressed specifically in mammalian oocytes, little was known about their function (Tian et al., 2009) . Here, we demonstrated that human NLRP14 (expression of which has been confirmed through an unbiased proteomics approach in oocytes; Wang et al., 2010) negatively regulates cytosolic sensing of DNA and RNA. Additionally, loss-and gain-of-function experiments revealed that NLRP14 targets TBK1 for ubiquitination and degradation, albeit through an as of yet unknown pathway. Similarly, there is growing evidence that the inflammasome family of proteins have non-inflammasome functions that are critical in maintaining tissue homeostasis and negatively regulate innate immune responses though none target cytosolic sensing of both DNA and RNA (Chen, 2014; Cui et al., 2010 Cui et al., , 2012 Guo et al., 2016; Kumar et al., 2011b; Lupfer and Kanneganti, 2013; Moore et al., 2008; Rathinam and Fitzgerald, 2016 tissue-specific requirements to control aberrant responses to self and foreign ligands. Indeed, the expression of NLRP14 is limited to gonadal tissues and immortalized cell lines such as 293T cells used in the present study. Here, we demonstrated that NLRP14 associates with both STING and MAVS and prevents downstream signal transduction (see model in Figure 7E ). In turn, these adaptor molecules induce the proteasomal degradation of NLRP14, a feedback loop that may be critical in preventing persistent immunosuppression and proper induction of innate immune responses under appropriate conditions (for example, after fertilization of oocytes). We found that ectopic expression of the K108X allele (rs76274604; coding for a nonsense mutation that introduces an early STOP codon immediately after the Pyrin domain and reduced expression of full-length NLRP14) resulted in reduced suppression of TBK1-mediated signaling. This allele has an average frequency of 1.7% in the human population and a minor allele frequency of 3% in East Asian and admixed American populations (Auton et al., 2015) , suggesting that infertility associated with homozygosity of this gene may affect 3 in 10,000 individuals. While NLRP14 mutations associated with female infertility have yet to be reported, the possibility cannot be ruled out and is the subject of further investigation. However, we found that a sub-cloned version of the allele, containing sequence for only aa 1-108 and lacking the coding sequence for aa 109-1,093, exhibited further enhancement of TBK1-mediated IFN-b and NF-kB activation. Recent work suggests that PYRIN domains can modulate inflammatory responses in human monocytes, macrophages, and dendritic cells through interactions with other inflammasome components (de Almeida et al., 2015) . Therefore, the enhancement in signaling we observe in the context of K108X-FL expression may be due to similar mechanisms, though further work will be necessary to explore this possibility. Satie et al. (2011) reported that the excess amount of type I IFN signaling disrupts seminiferous tubules in mice, leading to a loss of germ cells and infertility. Additionally, intra-peritoneal injection of IFN-a results in impaired spermatogenesis in rodents (Ulusoy et al., 2004) , and in infertile men, high levels of IFN-a were detected in semen (Fujisawa et al., 1998) . These reports support the notion that some NLRP14 mutations may cause spermatogenesis failure through inappropriate innate immune responses in testis. While the in vivo function of NLRP14 remains to be explored, microinjection of siRNA targeting NLRP14 into mouse oocytes results in aborted fertilization and early embryo development (Hamatani et al., 2004) and anecdotal evidence indicates that mice require a functional nlrp14 for sterility (data not shown). Furthermore, NLRP14 transcript levels appear to decrease with age, coinciding with reduced fertility (Hamatani et al., 2004) . Though these observations may be related to additional functions, such as polarization and maturation of fertilized oocytes, this is the first report that attributes any function to NLRP14 and describes an operative role for this protein in modulating innate recognition of nucleic acids.
Our combined findings highlight the importance of controlling innate immune responses to foreign and endogenous ligands and suggest that tight regulation of these processes is critical to maintain proper immunologic homeostasis in germline. In line with this idea, a recent report illustrates that NLRP3 inflammasome signaling and mitosis are mutually exclusive events that are controlled through interactions with NEK7, which mediates inflammasome assembly and activation (He et al., 2016; Shi et al., 2016) . Similarly, as an immunological rheostat, NLRP14 safeguards against inappropriate cytosolic responses to nucleic acids and the acquisition of such a function may have been a prerequisite to sexual reproduction. Homologs of the inflammasome family of proteins have been found widely across lifearguing in favor of their involvement in immunity and broader cellular processes, as is observed with other expanded gene families. Indeed, we found that mouse Nlrp14 inhibits the NAS pathway similarly to human NLRP14. In addition, knock-down of Ced-3, the C. elegans homolog of mammalian NLR proteins, results in reduced fertility and increased resistance to certain pathogens (Green et al., 2011; Jia et al., 2009; Maeda et al., 2001 )-a finding that further suggests evolutionary conservation of NLR proteins across life. Speculation aside, however, further studies will be necessary to clarify the molecular determinants that control NLRP14 function, including (1) identification of the ubiquitin ligase that mediates TBK1 targeting for degradation; (2) resolving the conformational dynamics that mediate NLRP14 protein stability and activity; and (3) the use of genetically engineered mice to determine whether manipulating NLRP14 expression could serve as a viable target of clinical importance.
EXPERIMENTAL PROCEDURES GTEx Data Analysis Data Preparation
To determine the set of genes with preferential expression in testis or ovary, we utilized tissue-specific gene expression data from the GTEx portal. For this particular analysis, we used the version 3 data (GTEx_Analysis_RNA-seq_RNA-SeQCv1.1.8_gene_reads__Pilot_V3_patch1.gct.gz) from https:// www.gtexportal.org/home/datasets2. Since the number of available samples was different for individual tissues, we randomly sampled 20 samples from 23 different tissues. Samples selected are listed in Table S1 . Tissues with fewer than 20 replicates (salivary gland, fallopian tube, kidney, cervix uteri, bladder, small intestine, bone marrow, blood) were excluded for downstream analysis. To minimize the potential batch effect of multiple platforms, we restricted our analysis to the samples generated from PAXgene Tissue miRNA Kit. We performed the multidimensional scaling with correlation distance to confirm that there were no batch effects in our selected samples.
Identification of Genes Preferentially Expressed in Testes and/ or Ovary
Differences in library size within the GTEx dataset were normalized using the Bioconductor package DESeq 1.20.0. To identify gonad-specific genes (expressed in gonads and not expressed in any other tissues), the following criteria had to be met:
1. No duplicate entries for any given gene. 2. Mean of normalized expression in testis or ovary had to be greater than 20 (this threshold was chosen to reflect the fact that there are 20 replicates, and on average each replicate should have at least one read to be considered as being expressed). 3. Within non-gonad tissues, normalized expression had to be less than 20. 4. Within non-gonad tissues, fold difference (FD) between testis (or ovary) and non-gonad tissue had to be greater than 2.
To quantify the expression specificity for testis and ovary, we used EdgeR (where expression is modeled as a linear combination of different tissue factors; Robinson et al., 2010 ) to obtain confidence scores (p values) for each gene. We used log likelihood ratio test to determine whether the mean expression of a given tissue is equal to that of the rest of the tissues. We selected those genes with multiple testing adjusted p value of less than 1%. This resulted in identifying 1,180 genes as being preferentially expressed in testes and/or ovary (Table S2) .
Using All GTEx Data and Redefining the Filter
As an alternative approach from the one described above (where the complete GTEx dataset was subsampled to yield results with lower computational power), we also used the full dataset to identify gonad-specific genes, with similar results. For this analysis, we downloaded ''GTEx_Analysis_V4_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct.gz'' from the GTEx portal (GTEx Consortium, 2013) . Similarly to the original analysis, we used the ''RNA isolation_PAXgene Tissue miRNA'' samples to minimize inherent batch effects that could be induced by different RNA preparations. In total, all 2,126 libraries spanning 29 tissues were used (Table S1 ).
In order to determine the threshold to use for presence or absence calls, we used the mean logRPKM as the expression unit in each tissue. The meanLogRPKM for GTEx data clearly follows a bimodal distribution indicating artifacts and real gene expressions. Based on this result, we used a value of À3 log RPKM as a threshold to call present or absent genes. We then used a pairwise one-tailed t test between gonadal and non-gonadal tissues to determine how significant the tissue specificity of a given gene was. We adjusted p values for multiple hypothesis testing and used a 0.01 cutoff.
Selection of Genes Regulated during Early Development
To screen for the set of genes expressed only in oocyte and not in the tissues of early embryos such as trophectoderm and inner cell mass, we downloaded the expression (measured in RPKM) of known RefSeq genes in 124 single cells from mature oocytes, preimplantation embryos, and embryonic stem cells from Yan et al. (2013) . We filtered for the genes whose RPKM expression values are greater than 1 in oocyte and equal to 0 in trophectoderm, endoderm, and epiblast. This resulted in 571 genes.
Cells
293T and A549 cells were obtained from ATCC, and Vero cells were kindly provided by Dr. Vincent Racaniello (Columbia University Medical Center). The stable cell lines, 293-ISRE-B8 cells containing a luciferase reporter gene (luc) under the control of ISRE (IFN-Stimulated Response Element), were described previously (Shapira et al., 2009 ). Cells were maintained in Dulbecco's modified Eagle's medium (DMEM; Life Technology) or Eagle's minimum essential medium (EMEM) supplemented with 10% fetal bovine serum (FBS; Hyclone Laboratories) and 1% penicillin and streptomycin (Life Technology). Singlecell 293T cell clones stably expressing STING-HA (293T-STING-HA) were generated by transduction of pLX302-STING-HA/BSD using LT-1 transfection reagent (Mirus) followed by selection with 10 mg/mL blasticidin (BSD). CRISPR/ Cas9 was used to target NLRP4 and NLRP14 in 293T cells and 293T-STING-HA cells and generate single-cell clones, which were maintained in DMEM supplemented with 10% FBS containing puromycin (Life Technology) at a final concentration of 1 mg/mL or blasticidin at a final concentration of 10 mg/mL. All cells were cultured at 37 C in a humidified atmosphere with 5% CO 2 .
Antibodies, Reagents, and Plasmids Antibodies specific to phosphorylated IRF3 (Ser396; 4D4G), phosphorylated IRF7 (Ser471/472), phosphorylated TBK1 (Ser172; D52C2), IkBa (L35A5), phosphorylated NFkBp65 (Ser536), and mouse monoclonal HA; 6E2) were purchased from Cell Signaling Technology (CST). TBK1 (EP611Y; Abcam cat# ab40676; RRID: AB_776632), and b-actin antibody (AC-15; Abcam cat# ab62760; RRID: AB_955467) were purchased from Abcam. Antibodies specific to IRF7 (H-246), IRF3 (FL-425), STAT1 (C-24), and Myc (9E10) were purchased from Santa Cruz Biotechnology. Mouse monoclonal anti-FLAG M2 was purchased from Sigma and mouse-a-V5 was purchased from Life Technology. Polyinosinic-polycytidylic acid (polyI:C) was purchased from Sigma and 2 0 3 0 -cGAMP (STING ligand) and poly(dA:dT) were purchased from Invivogen. Vesicular stomatitis virus (VSV) and Newcastle disease virus (NDV) carrying green fluorescein protein (GFP) were kindly provided by Dr. Vincent Racaniello (Columbia University Medical Center). Proteasome inhibitor (MG132) and Bafilomycin A1 were purchased from Sigma and Invivogen, respectively. Recombinant human IFN-b was purchased from PBL Biomedical Laboratories.
The plasmids encoding N-terminal Myc-tagged human NLRP14, NLRP4, IL17C, C4orf22, TRIM42, RIG-I, MAVS, TBK1, IRF3, or HA-tagged ubiquitin (HA-Ub) were purchased from TransOMIC Technologies and Addgene. ACTL7B, DMRTC2, CCDC27, ASZ1a, ZPLD1, C10orf120, FAM154A, SPERT, ZPBP2, TGIF2LX, INSL6, and LYPD4 were cherry picked from the human ORFeome Collection 8.1. cDNA encoding C5orf47 and IRF7 was generated reverse transcription-PCR from total RNA from human testis (included the Human Total RNA Master Panel II; Clontec Laboratories) and 293T cells, respectively, and subcloned into pcDNA3.1(-) (Life Technology). N-and C-terminal deletion mutants of FLAG-tagged NLRP14 (D1-100, D1-345, D531-1,093, and D109-1,093) and deletion mutants of TBK1 (DCC and DULD-CC) were amplified by PCR using Phusion High Fidelity DNA polymerase (Thermo Fisher) and subcloned into p3xFLAG-CMV-14 (Sigma). N-terminal Myc-tagged NLRP14 lacking the PYD, NACHT, or LRR domains, D1-345, K108X, or C-terminal FLAG-tagged NLRP14 SNP-containing mutants (D86V, A375T, D522Q, M1019I, K108X, transmembrane deleted version of MAVS D514-540, as well as S172A and K670R mutants of TBK1) were generated by PCR based sitedirected mutagenesis methods (Agilent Technologies). HA-tagged human cGAS and STING were kindly provided by Dr. Glen Barber (University of Miami School of Medicine) (Ishikawa and Barber, 2008) . IFN-b, NF-kB, and ISRE reporter constructs were kindly provided by Dr. Stephen Goff (Columbia University Medical Center). All constructions were sequence validated by GENEWIZ or ETON Bioscience.
Establishment of CRISPR/Cas9-Mediated Gene Editing Cell Clones 293T cells were transfected with pLenti-CRISPR/Cas9/puro plasmid encoding appropriate gRNA sequence (designed by using the GenScript gRNA design tool; http://www.genscript.com/CRISPR-gRNA-constructs.html) targeting exon 1 or 4 of human NLRP14 or exon 2 of human NLRP4. 5 hr after transfection, cells were seeded in 100 mm dishes and selected with puromycin at a final concentration of 1 mg/mL. Single-cell clones selected and gene editing was confirmed by DNA sequencing of purified genomic DNA (QIAamp DNA Mini Kit, QIAGEN). The primer pairs used for PCR amplification were as follows: for NLRP14 exon 1, Reporter Analysis Cells were stimulated with ligands at indicated concentrations and multiplicity of infection (moi; NDV-GFP) or transfected with poly(I:C) or B-DNA using LT-1 (Mirus). After 24 hr of incubation, supernatant was collected and 20 mL were transferred into 96-well microplates seeded with 293-ISRE-B8 cells. ISRE promoter-mediated luciferase activity was determined after 24 hr of incubation. Similarly, cells were cotransfected with reporter constructs encoding the luciferase gene under control of the IFN-b, NF-kB, or ISRE promoter. Luciferase activity was determined with dual-luciferase reporter assay system (Promega) at 24 hr post-transfection. All values shown are relative to Renilla luciferase reporter gene that was simultaneously monitored and used as an internal control.
Immunoprecipitation and Immunoblotting 293T cells were seeded into 6-well tissue culture plates for 24 hr and cotransfected with corresponding plasmids as indicated in each figure. Cells were harvested 48 hr after transfection and suspended in 0.4 mL RIPA lysis buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.1% SDS, 1% NP-40, 0.5% DOC, and Complete, EDTA-free protease inhibitor cocktail; Roche) at 4 C for 2 hr. Cell lysates were centrifuged at 14,000 3 g for 30 min at 4 C. The supernatant was immunoprecipitated with 1 mg of indicated antibodies and 30 mL of Dynabeads (Protein G; Life Technology) at 4 C overnight. The immunocomplex was then washed five times with 0.5 mL of RIPA lysis buffer. Proteins bound to the beads were boiled in 20 mL of Laemmli sample buffer (BIORAD) containing 5% b-mercaptoethanol and then subjected to NuPAGE 10% Bis-Tris Gel (Life Technology) and transferred to nitrocellulose membranes (Amersham protran 0.45 mm NC; GE Healthcare Life Science). Membranes were blocked with TBST containing 5% non-fat milk at room temperature for 2 hr and incubated with corresponding antibodies, followed by incubation with horseradish peroxidase (HRP)-conjugated goat a-mouse or a-rabbit polyclonal IgG (DAKO) at room temperature for 2 hr. Membranes were visualized with Supersignal West Femto Maximum Sensitivity Substrate (Thermo Scientific) and detected using ChemDoc Touch Imaging System (BIORAD).
Cell Fractionation
Cells were seeded into 6-well tissue culture plates for 24 hr and cotransfected with indicated plasmids. 24 hr later, transfected cells were inoculated with NDV-GFP at an moi of 10 and fractionated after a 24 hr incubation. In brief, cytoplasmic fractions were isolated with hypotonic lysis buffer (10 mM HEPES [pH 7.75], 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, 0.1% NP-40, and protease inhibitors) at 4 C for 10 min. Nuclear fractions were isolated with high salt nuclei extraction buffer (20 mM HEPES [pH 7.5], 420 mM NaCl, 1 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 0.4% NP-40, and protease inhibitors) at 4 C for 60 min.
Real-Time PCR Total cellular RNA was prepared by using RNeasy mini kit (QIAGEN). Firststrand cDNA was synthesized by using ProtoScript II First Strand cDNA Synthesis Kit (NEB). Real-time PCR was performed by using FastStart Universal SYBR green master (Rox; Roche) according to the manufacturer's protocol. 
